3D Systems (DDD) 27th Annual Needham Growth Conference summary
Event summary combining transcript, slides, and related documents.
27th Annual Needham Growth Conference summary
10 Jan, 2026Industry environment and challenges
The past six quarters were among the most difficult, with weak customer CapEx spending severely impacting revenue and prompting aggressive cost reductions.
R&D investment was maintained to support long-term growth, despite cost-cutting measures.
Healthcare, especially orthopedics, remained stable and less cyclical, while industrial and dental segments were more affected by capital spending cycles.
Geopolitical uncertainty, elections, and talk of tariffs contributed to customer hesitancy in capital investment.
Strategic focus and market development
Investments are concentrated in high-resolution projection systems, metal printing, and materials development for both healthcare and industrial markets.
The application engineering group, which supports new customer applications, grew 26% in Q3, indicating strong future demand.
Industrial focus is on high-reliability markets like aerospace, defense, and AI infrastructure, which are expected to drive stable growth.
Healthcare growth is led by orthopedics and a digital transformation in dentistry, with new products like 3D-printed dentures and night guards.
Operational improvements and supply chain
Manufacturing has been largely in-sourced, reducing exposure to tariffs, improving quality control, and lowering costs.
Domestic sourcing and minimized reliance on China have strengthened supply chain resilience.
Inventory build-up from insourcing is being managed, with expectations of future margin improvement.
Latest events from 3D Systems
- Q4 2025 saw 16% sequential growth, margin gains, and $55M in cost savings, led by key segments.DDD
Q4 20259 Mar 2026 - Q2 revenue rose sequentially, margin improved, and full-year outlook targets breakeven Q4.DDD
Q2 202422 Jan 2026 - FDA-approved 3D printed dentures and aerospace growth position the business for major expansion.DDD
28th Annual Needham Growth Conference Virtual13 Jan 2026 - Q3 revenue fell 9% YoY to $112.9M, with a $178.6M net loss from impairment charges.DDD
Q3 202412 Jan 2026 - Dental and healthcare 3D printing lead growth, with cost control and new products driving profitability.DDD
Cantor Fitzgerald Global Technology Conference26 Dec 2025 - 2024 revenue hit $440M; cost cuts and Geomagic sale target break-even EBITDA by Q4 2025.DDD
Q4 20241 Dec 2025 - Annual meeting to vote on directors, pay, incentive plan, and auditor, with focus on ESG and governance.DDD
Proxy Filing1 Dec 2025 - Shareholders to vote on key proposals as leadership addresses internal control remediation.DDD
Proxy Filing1 Dec 2025 - Virtual annual meeting to elect nine directors, approve pay, and ratify auditor on May 16, 2025.DDD
Proxy Filing1 Dec 2025